Link between diabetes drug use and stomach contents in fasting patients having anesthetized endoscopy

Glucagon-like peptide-1 treatment linked to food in the stomach of fasting patients during sedated endoscopy

Link between glucagon-like peptide-1 receptor treatment and stomach contents in fasting patients having sedated endoscopy

Use of diabetes drugs during surgery and leftover stomach contents in patients having planned upper digestive exams

Link between using glucagon-like peptide-1 receptor drugs and lung aspiration during surgery: a systematic review and analysis

Effects of diabetes drugs on anesthesia and procedure outcomes in patients having outpatient upper digestive tract exams

Use of Glucagon-Like Peptide-1 Drugs and Remaining Stomach Contents Before Anesthesia

Glucagon-like peptide-1 receptor drugs may raise the risk of leftover stomach contents and lung aspiration during upper endoscopy

Is it necessary to stop diabetes drugs that activate glucagon-like peptide-1 receptors before an endoscopy? A look back at past cases

Use of Glucagon-like Peptide-1 Drugs Before Upper Stomach and Throat Exams and the Risk of Breathing Problems or Stopping the Procedure

Use of glucagon-like peptide-1 receptor drugs and the risk of leftover stomach contents and choking during digestive system exams